Effect of TTP488 in patients with mild to moderate Alzheimer's disease

Effect of TTP488 in patients with mild to moderate Alzheimer's disease

BACKGROUND:TTP488, an antagonist at the Receptor for Advanced Glycation End products, was evaluated as a potential treatment for patients with mild-to-moderate Alzheimer's disease (AD). A previous report describes decreased decline in ADAS-cog (delta=3.1, p=0.008 at 18 months, ANCOVA with multi...

Full description

Bibliographic Details
Main Authors:	Burstein, Aaron, Grimes, Imogene, Galasko, Douglas, Aisen, Paul, Sabbagh, Marwan, Mjalli, Adnan
Other Authors:	TransTech Pharma, High Point, NC, USA
Language:	en
Published:	BioMed Central 2014
Online Access:	Burstein et al. BMC Neurology 2014, 14:12 http://www.biomedcentral.com/1471-2377/14/12 http://hdl.handle.net/10150/610067 http://arizona.openrepository.com/arizona/handle/10150/610067

Similar Items

Broader Considerations of Higher Doses of Donepezil in the Treatment of Mild, Moderate, and Severe Alzheimer's Disease
by: Camryn Berk, et al.
Published: (2012-01-01)

Characteristics of falls in mild and moderate Alzheimer's disease
by: Eliane Mayumi Kato-Narita, et al.

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology
by: Cummings Jeffrey, et al.
Published: (2011-02-01)

Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
by: Michael F. Egan, et al.
Published: (2019-08-01)

Neuropsychological Rehabilitation in Mild and Moderate Alzheimer’s Disease Patients
by: Renata Ávila, et al.
Published: (2007-01-01)

The conceptual relevance of assessment measures in patients with mild/mild‐moderate Alzheimer's disease
by: Ann Hartry, et al.
Published: (2018-01-01)

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
by: Brian Lawlor, et al.
Published: (2018-09-01)

Expanding the repertoire of biomarkers for Alzheimer’s disease: targeted and non-targeted approaches.
by: Douglas eGalasko
Published: (2015-12-01)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
by: Ben Seltzer
Published: (2009-12-01)

Research progress of donepezil for treating mild to moderate Alzheimer's disease
by: Xin-xin LI, et al.
Published: (2017-02-01)

ANOSOGNOSIA, MOOD AND PERSPECTIVE-TAKING IN MILD TO MODERATE ALZHEIMER S DISEASE
by: ELODIE BERTRAND
Published: (2017)

Experience of People in Mild and Moderate Stages of Alzheimer’s Disease in Spain
by: Jorge Riquelme-Galindo, et al.
Published: (2020-12-01)

Q & A: The Alzheimer's disease neuroimaging initiative
by: Aisen Paul S
Published: (2011-09-01)

[en] ANOSOGNOSIA, MOOD AND PERSPECTIVE-TAKING IN MILD TO MODERATE ALZHEIMER S DISEASE
by: ELODIE BERTRAND
Published: (2018)

Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil
by: Luciana R. da Silva, et al.
Published: (2018-11-01)

Determinants of response to acetylcholinesterase inhibitors in patients with mild to moderate Alzheimer's disease
by: Patterson, C. E.
Published: (2004)

Recent developments in Alzheimer's disease therapeutics
by: Aisen Paul S, et al.
Published: (2009-02-01)

KIF6 719Arg Carrier Status Association with Homocysteine and C-Reactive Protein in Amnestic Mild Cognitive Impairment and Alzheimer’s Disease Patients
by: Michael Malek-Ahmadi, et al.
Published: (2013-01-01)

Peripheral Biomarkers for Alzheimer’s Disease: Update and Progress
by: Marwan N. Sabbagh, et al.
Published: (2019-12-01)

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
by: Mona Mehta, et al.
Published: (2012-01-01)

Pregnancy Induced Microangiopathy, HELLP OR TTP!
by: Ahmed Amro, et al.
Published: (2015-01-01)

Spinoza: A Baconian in the TTP, but Not in the Ethics?
by: Jo Van Cauter, et al.
Published: (2021-04-01)

Acupuncture for patients with mild to moderate Alzheimer’s disease: a randomized controlled trial
by: Yujie Jia, et al.
Published: (2017-12-01)

Analysis of word number and content in discourse of patients with mild to moderate Alzheimer's disease
by: Juliana Onofre de Lira, et al.

Quantitative electroencephalography power and coherence measurements in the diagnosis of mild and moderate Alzheimer's disease
by: L C Fonseca, et al.
Published: (2011-01-01)

Quantitative electroencephalography power and coherence measurements in the diagnosis of mild and moderate Alzheimer's disease
by: Lineu Corrêa Fonseca, et al.
Published: (2012-12-01)

Illness representations and informational expectations of patients and their carers in mild to moderate Alzheimer's disease
by: Phillips, Deborah Anne
Published: (2003)

Selective impairment of musical emotion recognition in patients with amnesic mild cognitive impairment and mild to moderate Alzheimer disease
by: Shan-Shan Zhou, et al.
Published: (2019-10-01)

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease
by: Seema Patel, et al.
Published: (2011-01-01)

Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer’s Disease?
by: Lih-Fen Lue, et al.
Published: (2012-01-01)

Naming ability in patients with mild to moderate Alzheimer’s disease: what changes occur with the evolution of the disease?
by: Marcela Lima Silagi, et al.

Photo-Elicitation with Autodriving in Research with Individuals with Mild to Moderate Alzheimer's Disease: Advantages and Challenges
by: Lynn Shell PhD, RN, FMHNP-BC
Published: (2014-02-01)

Evaluation of inner retinal layers as biomarkers in mild cognitive impairment to moderate Alzheimer's disease.
by: Eleonora M Lad, et al.
Published: (2018-01-01)

Balance impairment does not necessarily coexist with gait apraxia in mild and moderate Alzheimer’s disease
by: Fernando Vieira Pereira, et al.
Published: (2016-06-01)

Assessment of balance in mild and moderate stages of Alzheimer's disease: implications on falls and functional capacity
by: Eliane Mayumi Kato-Narita, et al.
Published: (2011-04-01)

Retrospective case studies of the efficacy of caprylic triglyceride in mild-to-moderate Alzheimer's disease
by: Maynard SD, et al.
Published: (2013-10-01)

Bapineuzumab for mild to moderate Alzheimer’s disease: a meta-analysis of randomized controlled trials
by: Abdelrahman Ibrahim Abushouk, et al.
Published: (2017-04-01)

Novel Therapeutics in Alzheimer's Disease
by: Marwan Sabbagh, et al.
Published: (2012-01-01)

From TTP to Glomerulonephritis: A Lifetime of Lupus
by: Fadi Kharouf, et al.
Published: (2021-01-01)

Elevations in Serum Dickkopf-1 and Disease Progression in Community-Dwelling Older Adults With Mild Cognitive Impairment and Mild-to-Moderate Alzheimer’s Disease
by: Laura Tay, et al.
Published: (2019-10-01)